| Autor: |
Kate McAdam, Cinzia Bordoni, Miller Duncan Charles, Daniel J. Brough, James H. Hunter, Pasquale A. Morese, Nikolay Sitnikov, Mélanie Uguen, Gemma Davison, J. Daniel Lopez-Fernandez, Paul Ratcliffe, Alexia Papaioannou, Michael J. Waring |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
The Medicinal Chemist's Guide to Solving ADMET Challenges ISBN: 9781788012270 |
| DOI: |
10.1039/9781788016414-00403 |
| Popis: |
Interaction with cardiac ion channels can potentially result in severe or even fatal cardiac side effects. The most prominent of cardiac channels, human ether-a-go-go-related gene (hERG), voltage-gated sodium channel 1.5 (NaV1.5) and voltage-gated calcium channel 1.2 (CaV1.2), which traffic major ion currents shaping cardiac action potential, are recognized as primary counter-screen targets. These channels possess relatively large inner pores with multiple binding sites and can accommodate a variety of structurally diverse ligands. This chapter provides a short overview of in vitro approaches in preclinical cardiotoxicity screening, gives a summary of available structural data and pharmacophore models for hERG, NaV1.5 and CaV1.2 as well as discusses medicinal chemistry strategies that were successfully applied to mitigate cardiotoxicity risk. The major highlighted approaches are lipophilicity reduction, basicity reduction and removal or modification of (hetero)aromatic substituents. The strategies are illustrated by multiple examples from recent literature. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
